Fig. 3.

OABL attenuated cognitive impairments in 5xFAD transgenic AD mice

(A) Experimental workflow of animal treatments (n = 8); (B) representative tracks of the test during the probe trial on day 5; (C) the escape latency of different groups on day 1, day 3, and day 5; (D) the time spent in target quadrant on day 6. The statistical analysis was performed via two-way ANOVA with Newman-Keuls multiple comparisons test, and the data are presented as the means ± SEM with significance different from each other (n = 6–8), (*) p < 0.05, (**) p < 0.01. n.s.: not significant.